Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

2 Citationer (Scopus)

Adgang til dokumentet

@article{49d9fbd679644ac5bb4d5d6f84eed85b,

title = "Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab",

author = "Chodziuk, {Astrid C.} and Ghazanfar, {Misbah N.} and Thomsen, {Simon F.}",

year = "2019",

doi = "10.1111/dth.12902",

language = "English",

volume = "32",

journal = "Dermatologic Therapy",

issn = "1396-0296",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab

AU - Chodziuk, Astrid C.

AU - Ghazanfar, Misbah N.

AU - Thomsen, Simon F.

PY - 2019

Y1 - 2019

U2 - 10.1111/dth.12902

DO - 10.1111/dth.12902

M3 - Letter

C2 - 30964569

VL - 32

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 3

M1 - e12902

ER -